Insider Transactions in Q1 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-63.33%
|
$3,350,000
$67.5 P/Share
|
|
Jan 20
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 20
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-56.4%
|
$1,005,000
$67.47 P/Share
|
|
Jan 20
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-69.96%
|
$3,350,000
$67.48 P/Share
|
|
Jan 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.66%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
25,000
-71.43%
|
$1,725,000
$69.0 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Exercise of conversion of derivative security
|
Direct |
23,000
-39.66%
|
$92,000
$4.07 P/Share
|
|
Jan 19
2021
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.29%
|
$0
$0.84 P/Share
|
|
Jan 19
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-68.18%
|
$1,050,000
$70.0 P/Share
|
|
Jan 19
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 19
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-52.24%
|
$3,400,000
$68.95 P/Share
|
|
Jan 19
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.66%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-44.64%
|
$3,400,000
$68.82 P/Share
|
|
Jan 19
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 19
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
8,400
-0.24%
|
$588,000
$70.78 P/Share
|
|
Jan 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
417
-100.0%
|
$28,773
$69.0 P/Share
|
|
Jan 19
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+50.0%
|
$2,502
$6.27 P/Share
|
|
Jan 15
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-72.25%
|
$132,000
$66.51 P/Share
|
|
Jan 15
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Jan 15
2021
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-84.45%
|
$132,000
$66.7 P/Share
|
|
Jan 15
2021
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Jan 15
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-72.3%
|
$990,000
$66.38 P/Share
|
|
Jan 15
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-92.01%
|
$396,000
$66.1 P/Share
|
|
Jan 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$42,000
$7.8 P/Share
|
|
Jan 14
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-91.8%
|
$975,000
$65.92 P/Share
|
|
Jan 14
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 13
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-64.09%
|
$3,150,000
$63.28 P/Share
|
|
Jan 13
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.51%
|
$300,000
$6.32 P/Share
|
|
Jan 13
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-77.05%
|
$945,000
$63.26 P/Share
|
|
Jan 13
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 12
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,000
-67.01%
|
$4,650,000
$62.98 P/Share
|
|
Jan 12
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+49.67%
|
$450,000
$6.32 P/Share
|
|
Jan 12
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-82.91%
|
$930,000
$62.79 P/Share
|
|
Jan 12
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 11
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-46.23%
|
$900,000
$60.68 P/Share
|
|
Jan 11
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
8,814
-42.54%
|
$520,026
$59.96 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
BUY
Open market or private sale
|
Direct |
6,186
+55.58%
|
$371,160
$60.44 P/Share
|
|
Jan 08
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 07
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$855,000
$57.3 P/Share
|
|
Jan 07
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 06
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-97.31%
|
$825,000
$55.16 P/Share
|
|
Jan 06
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 05
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-98.79%
|
$840,000
$56.27 P/Share
|
|
Jan 05
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 04
2021
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
15,000
-66.55%
|
$855,000
$57.77 P/Share
|
|
Jan 04
2021
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Jan 04
2021
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
6,771
-70.22%
|
$392,718
$58.01 P/Share
|